Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia

Cancer Chemotherapy and Pharmacology

Volumn 33, Issue 5, 1994, Pages 359-365

  Nagura, Eiichi ^a   Kimura, Kiyoji ^b   Yamada, Kazumasa ^c   Ota, Kazuo ^d   Maekawa, Tadashi ^e   Takaku, Fumimaro ^f   Uchino, Haruto ^g   Masaoka, Toru ^h   Amaki, Ichita ⁱ   Kawashima, Kohei ^c   Ohno, Ryuzo ^c   Nomura, Takeo ^j   Hattori, Jun ichi ^k   Kawamura, Setsuko ^l   Shibata, Akira ^m   Shirakawa, Shigeru ⁿ   Hamajima, Nobuyuki ^o  

^a CHUBU NATIONAL HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e GUNMA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g KYOTO UNIVERSITY   (Japan)

^h CENTER FOR ADULT DISEASES   (Japan)

ⁱ NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j NIPPON MEDICAL SCHOOL   (Japan)

^k KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^l HIROSAKI UNIVERSITY   (Japan)

^m NIIGATA UNIVERSITY   (Japan)

ⁿ MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHI-SQUARE DISTRIBUTION; DOXORUBICIN; FEMALE; HUMANS; JAPAN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; PREDNISOLONE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0028085149     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00686263     Document Type: Article

References (19)

1. Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy, a study of 293 patients
2. Acute lymphoblastic leukemia in adults: clinicopathological correlations with the French-British-American Co-operative Group Classification
3. Acute lymphoblastic leukemia: recent advances in biology and therapy
4. The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukemia
5. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and acute leukemia group B
6. Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo
7. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
8. Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy
9. Optimal use of L-asparaginase in acute lymphocytic leukemia
10. High efficacy of monomethoxypolyethylene glycol-conjugated L-asparaginase (PEG2-ASP) in two patients with hematological malignancies
11. Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia
12. Improved results of adult acute lymphoblastic leukemia
13. Multivariate analysis of factors associated with prognosis for adult acute leukemia
14. A controlled randomized clinical trial of adult acute leukemia
15. Toxicity of E. coli L-asparaginase in man
16. L-Asparaginase, vincristine and prednisone for induction of first remission in acute lymphocytic leukemia
17. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of bleeding coagulation
18. Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10 M protocols